Clinical Trials

235 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT06112613 2026-04-03

Mobile Health for Adherence in Breast Cancer Patients

410 enrolled

Breast Neoplasms

NCT03723928 2026-04-02

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

739 enrolled

Phase NA Active not recruiting

Anatomic Stage IV Breast Cancer AJCC v8

NCT05568472 2026-04-02

ASPEN

565 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT02445391 2026-04-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

415 enrolled 15 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00003140 2026-03-27

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Phase 3 Completed

5,187 enrolled

Breast Neoplasms

NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Phase 1/2 Completed

93 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03568422 2026-03-27

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

37 enrolled 14 charts

Breast Neoplasms

NCT05601440 2026-03-27

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Phase 2 Recruiting

484 enrolled

Breast Neoplasms

NCT03233191 2026-03-23

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

108,508 enrolled

Breast Screening

NCT04266249 2026-03-23

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

2,175 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT04316117 2026-03-23

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

138 enrolled

Breast Neoplasms

NCT04001829 2026-03-13

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

249 enrolled 14 charts

Anatomic Stage I Breast Cancer AJCC v8

NCT01349322 2026-03-05

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

2,354 enrolled 29 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05896566 2026-02-24

PREcoopERA

Phase 2 Completed

231 enrolled

Breast Neoplasms

NCT07425002 2026-02-20

PRISM

1,600 enrolled

Breast Neoplasms

NCT04176848 2026-02-18

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

15 enrolled 7 charts

Breast Neoplasms

NCT01674140 2026-02-10

e3

1,939 enrolled 15 charts

Phase NA Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT02308085 2026-02-09

POSITIVE

518 enrolled

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

Phase 3 Completed

2,672 enrolled 14 charts

Breast Neoplasms

NCT03624543 2026-01-30

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

51 enrolled

Breast Neoplasms

NCT06995443 2026-01-30

REGAIN

200 enrolled

Phase NA Active not recruiting

Breast Neoplasms, Neoplasms, Cognitive Dysfunction

NCT02352883 2025-12-19

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

368 enrolled

Carcinoma, Intraductal, Noninfiltrating

NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

2,400 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT07084558 2025-10-28

TEODOR

350 enrolled

Breast Neoplasms

NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

491 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

NCT03283384 2025-09-19

NEOLBC

100 enrolled

Breast Neoplasms

NCT03425838 2025-09-19

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

1,050 enrolled

Breast Neoplasm Female

NCT03820063 2025-09-19

TRAIN-3

462 enrolled

Breast Neoplasms

NCT04489173 2025-09-19

TIBET

52 enrolled

Breast Neoplasms

NCT05392608 2025-09-17

SEQUEL-Breast

130 enrolled

Breast Neoplasms, Genetic Diseases, Inborn

NCT01766297 2025-09-09

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Phase 2 Recruiting

132 enrolled

Breast Neoplasms

NCT05856773 2025-09-09

COMPRO

276 enrolled

Breast Neoplasms

NCT01758445 2025-09-04

Proton Radiation for Stage II/III Breast Cancer

220 enrolled

Breast Neoplasms, Neoplasms

NCT05512364 2025-08-19

TREAT ctDNA

220 enrolled

Phase NA Not yet recruiting

Breast Neoplasms

NCT07122492 2025-08-14

FoRtitude

800 enrolled

Breast Cancer Survivor

NCT06462963 2025-08-01

SPRINT

BreastGastrointestinalGenitourinary

302 enrolled

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00070564 2025-07-31

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

3,294 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT04042051 2025-07-22

Panthera

Phase 1 Terminated

2 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00963417 2025-07-14

TEXT-Bone

Phase NA Completed

119 enrolled